Clinical trial
Evaluating the Use of Repetitive Transcranial Magnetic Stimulation in Cancer Patients With Chemotherapy-Induced Peripheral Neuropathy: A Randomized Feasibility Study
NCT04107272 is registered in ClinicalTrials.gov with The Hong Kong Polytechnic University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Use of Repetitive Transcranial Magnetic Stimulation in Cancer Patients With Chemotherapy-Induced Peripheral Neuropathy: A Randomized Feasibility Study
- Lead sponsor
- The Hong Kong Polytechnic University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 31, 2022
- Completion date
- March 31, 2024
- Enrollment
- 60 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
chemotherapy-induced peripheral neuropathy